Evidence map›Paper›PMID 33219646›Full record

ArticleEmerging infectious diseases2020

Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia.

Katherine Laiton-Donato, Christian Julián Villabona-Arenas, José A Usme-Ciro, Carlos Franco-Muñoz, Diego A Álvarez-Díaz, Liz Stephany Villabona-Arenas, Susy Echeverría-Londoño, Zulma M Cucunubá, Nicolás D Franco-Sierra, Astrid C Flórez and 7 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The unfurl of the coronavirus and its thwack on humans and the environment: a review.Current opinion in environmental science & health · 2021
    Review
  13. Article
  14. Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Katherine Laiton-Donato
Christian Julián Villabona-Arenas
José A Usme-Ciro
Carlos Franco-Muñoz
Diego A Álvarez-Díaz
Liz Stephany Villabona-Arenas
Susy Echeverría-Londoño
Zulma M Cucunubá
Nicolás D Franco-Sierra
Astrid C Flórez
Carolina Ferro
Nadim J Ajami
Diana Marcela Walteros
Franklin Prieto
Carlos Andrés Durán
Martha Lucia Ospina-Martínez
Marcela Mercado-Reyes

Funding

Medical Research Council MC_PC_19012Medical Research Council MR/R015600/1Medical Research Council MR/R024855/1
6 · The paper itself

Abstract

Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical samples we collected, along with another 79 genome sequences available from Colombia. We investigated the emergence and importation routes for SARS-CoV-2 into Colombia by using epidemiologic, historical air travel, and phylogenetic observations. Our study provides evidence of multiple introductions, mostly from Europe, and documents >12 lineages. Phylogenetic findings validate the lineage diversity, support multiple importation events, and demonstrate the evolutionary relationship of epidemiologically linked transmission chains. Our results reconstruct the early evolutionary history of SARS-CoV-2 in Colombia and highlight the advantages of genome sequencing to complement COVID-19 outbreak investigations.

Indexed as

Genome, ViralPhylogenyColombiaCOVID-19GenomicsHumansReproducibility of ResultsSARS-CoV-2Colombiacoronaviruscoronavirus diseaseCOVID-19genome sequencingphylogenomicsrespiratory infectionsSARSSARS-CoV-2severe acute respiratory syndrome coronavirus 2viruseszoonoses

Identifiers

PMID33219646
PMCPMC7706936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.